Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis
Authors:
Open Access
- 21 November 2023
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 23 (1) , 1-8
Abstract
Background: Cough and sputum are major symptoms in cystic fibrosis (CF) that contribute to the impairment of quality of life. Methods: This prospective single centre cross-sectional pilot study aimed to evaluate the results of a self-administered questionnaire assessing cough and sputum symptoms (2 domains), and their impact (2 domains) on daily activities in the previous week, named the Cough and Sputum Assessment Questionnaire (CASA-Q) in CF adult patients at stable state, and to analyse associations with clinical, functional, microbiological, radiological data, and two quality of life scales: the Cystic Fibrosis Questionnaire Revised (CFQ-R) and the Saint George Respiratory Questionnaire (SGRQ). Results: Forty-eight patients were included in this analysis (69% men; median age of 27.8 ± 8.1 years; median body mass index of 21.8 + 3.3 kg/m²; mean FEV1 of 64 ± 30% of the predicted value). The mean values of the CASA-Q domains were 58 ± 23 for cough symptoms, 77 ± 24 for cough impact, 62 ± 25 for sputum symptoms and 84 ± 21 for sputum impact. Impairment in CASA-Q cough and sputum domains was associated with dyspnea mMRC scale (p < 0.005 for all 4 domains of CASA-Q) and exacerbations in the previous year (p < 0.05 for CASA-Q symptoms domains). We also found correlations between all domains of the CASA-Q and quality of life questionnaires including SGRQ (p < 0.001) and to a lesser extend CFQ-R. We identified a clinical phenotype (female gender, ΔF508 heterozygous mutation, dyspnea mMRC scale) associated with an impairment of CASA-Q score and quality of life using a 2-step cluster analysis. Conclusions: CASA-Q allows the assessment of cough and sputum in CF adult patients and is associated with quality of life impairment. This simple easy-to-use tool could be used in routine clinical practice and in clinical studies to assess cough and sputum in CF patients. Trial Registration: The study was registered on ClinicalTrials.gov (NCT02924818, first posted on 5th October 2016).Keywords
All Related Versions
Funding Information
- University Hospital of Reims
- Université de Reims Champagne-Ardenne
This publication has 27 references indexed in Scilit:
- Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sampleQuality of Life Research, 2012
- Associations between illness perceptions and health-related quality of life in adults with cystic fibrosisJournal of Psychosomatic Research, 2011
- Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitisRespiratory Medicine, 2010
- Patient-reported respiratory symptoms in cystic fibrosisJournal of Cystic Fibrosis, 2009
- Cystic fibrosisThe Lancet, 2009
- Development and validation of a cough and sputum assessment questionnaireRespiratory Medicine, 2008
- Fleischner Society: Glossary of Terms for Thoracic ImagingRadiology, 2008
- Patient-reported Outcomes in Cystic FibrosisProceedings of the American Thoracic Society, 2007
- Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patientsJournal of Cystic Fibrosis, 2003
- Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosaThe Journal of Pediatrics, 1990